Log In
Print this Print this

Prevacid, Takepron, lansoprazole (AG-1749)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionBenzimidazole proton pump inhibitor (PPI)
Molecular Target H+/K ATPase pump
Mechanism of ActionH+/K+ ATPase pump inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsRisk reduction of non-steroidal anti-inflammatory drug (NSAID)-associated gastric ulcer; Treat gastroesophageal reflux disease (GERD); Treat gastroesophageal reflux disease (GERD) and erosive esphagitis in children ages 1 to 11
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today